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Familial nephrotic syndrome: Clinical spectrum and linkage to biopsy in children who respond to steroids usually shows
chromosome 19q13. minimal change disease (MCD), which is usually associ-
Background. Familial nephrotic syndrome (NS) has both ated with a favorable prognosis [1]. Conversely, steroidautosomal dominant and recessive forms of inheritance. Recent
nonresponsive NS has a poorer prognosis and is morestudies in families with an autosomal dominant form of focal
frequently associated with pathologies such as focal seg-segmental glomerulosclerosis (FSGS) have been at odds con-
cerning linkage to chromosome 19q13 (Mathis et al, Kidney mental glomerulosclerosis (FSGS) and mesangioprolifer-
Int 53:282–286, 1998; Winn et al, Kidney Int 55:1241–1246, 1999), ative glomerulonephritis (GN) [1, 2]. Minimal change
suggesting genetic heterogeneity. This study examines the clini- nephrotic syndrome (MCNS) and FSGS are thought tocal features and confirms linkage to chromosome 19q13 in a
be two very distinct pathologic entities with significantfamily with autosomal dominant NS.
differences in clinical presentation and outcome; how-Methods. DNA samples were obtained from 16 of 17 family
members. Genomic DNA was isolated, and polymerase chain ever, progression from MCNS and mesangioproliferative
reaction was performed for five markers spanning the area of GN to FSGS has been reported in both steroid-respon-
interest on chromosome 19q13. Data were evaluated using two- sive and steroid-nonresponsive NS patients [1–3].and six-point linkage analysis.
The mechanisms underlying the etiopathogenesis ofResults. Clinical features included presentation of NS in
MCNS/FSGS remain unclear, although genetic factorschildhood, steroid unresponsiveness, and slow progression to
renal failure. Renal biopsy in affected family members showed have been implicated in various studies, even though
lesions ranging from minimal change to mesangial proliferative idiopathic NS is generally regarded as a sporadic disease.
glomerulonephritis to FSGS. Linkage was confirmed between Several observations point toward a genetic susceptibil-the disease state and chromosome 19q13, with a maximum
ity to NS, as familial cases have been reported periodi-logarithm of odds (LOD) score of 2.41. Linkage was observed
cally, and congenital NS of the Finnish type (CNF) is afor a 7 cM region on chromosome 19q13, defined by markers
D19S425 and D19S220. well-recognized heritable form of NS [1]. Previous stud-
Conclusions. This study confirms the Mathis et al report ies have also reported human lymphocyte antigen (HLA)
of linkage to chromosome 19q13 in a family with autosomal linkage to various antigens for both MCD and FSGSdominant NS. However, there were notable differences in the
[4–6]. However, the genes responsible for these pheno-presenting clinical and histopathologic features of our affected
types have not been elucidated. Recently, both autoso-family members compared with those of Mathis et al. This
suggests that the gene on chromosome 19q13 may be responsible mal dominant and recessive forms of familial NS have
for considerable phenotypic heterogeneity and variable expres- been identified [7–11]. The reported autosomal domi-
sion in both clinical presentation and renal histopathology. nant forms of NS are generally less severe than the reces-
sive forms. Although FSGS is the most common histo-
pathologic lesion in patients with familial NS, the clinical
Massive proteinuria, hypoalbuminemia, and edema features vary widely in age of presentation and rate of
characterize idiopathic nephrotic syndrome (NS). Renal progression to end-stage renal disease (ESRD). Hence,
elucidation of genetic factors associated with various her-
itable forms of NS may allow for a greater understandingKey words: inherited disease, focal segmental glomerulosclerosis, mini-
mal change disease, linkage analysis, progressive renal failure. of etiopathogenesis, and possibly lead to a more precise
classification and new therapeutic approaches.Received for publication May 13, 1999
Recently, linkage analysis has been reported in twoand in revised form September 3, 1999
Accepted for publication September 16, 1999 large pedigrees with autosomal dominant NS in which the
primary pathology was FSGS. In the first study, MathisÓ 2000 by the International Society of Nephrology
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Fig. 1. Children’s Hospital of Pittsburg (CHP) family 101 pedigree. The pedigree has been altered to preserve anonymity of the family. The
three-digit numbers located under the individual number refer to chromosomal marker used in the study. Symbols are: (h) male; (s) female; (j)
affected; (j) deceased./
et al reported a kindred from Oklahoma with linkage to biopsies. An evaluation of the affected family members
included a complete history, physical examination, anda narrow region on chromosome 19q13 [8, 9]. This region
laboratory investigations, including assays of serum cre-also includes the gene for CNF [12–14]. However, Winn et
atinine and urinary protein. Asymptomatic individualsal excluded linkage to the same locus in a large New Zea-
were screened for proteinuria by semiquantitative uri-land family with a similar disease and inheritance pattern
nalysis (dipstick). Family members were considered af-[11], suggesting genetic heterogeneity. In this study, we
fected if they had a documented proteinuria of greaterreport a family from Pittsburgh with autosomal dominant
than 31 on urinalysis, a urinary protein to creatinineNS with significantly different clinical and histopathologi-
ratio of greater than 2.0, or a 24-hour urine protein excre-cal features in which the trait maps to chromosome 19q13.
tion of greater than 2 g. One child (III:6) was considered
affected, although she had a proteinuria of 21 because
METHODS her serum albumin was 2.1 g/dL. Of the 17 family mem-
The study family (#101) has been followed at the Chil- bers, 10 were considered affected.
dren’s Hospital of Pittsburgh (CHP) since 1969. The Peripheral blood was obtained on 15 family members,
family is a 17-member kindred spanning three genera- and an oral mucosal brushing was acquired from one
tions (Fig. 1). One of the family members is deceased family member (III:7) for DNA extraction. Studies were
(I:2). Six affected family members have undergone renal performed after obtaining informed consent in accor-
biopsy over the years (Table 1). The biopsy on I:2 was not dance with a protocol approved by the Human Rights
available for review. One member (III:4) was biopsied at Committee at CHP.
Texas Children’s Hospital, and the four remaining family
DNA isolation and genotypingmembers were biopsied at CHP. Two of the patients
were biopsied twice (II:2 and II:5). P.S.R. reviewed the DNA was isolated from ethylenediaminetetraacetic
acid (EDTA) anticoagulated whole blood and cheekhistopathology independently on all available renal
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Table 1. Selected clinical characteristics of Children’s Hospital of Pittsburgh (CHP) family 101
Laboratory Values at Presentation
UrineCurrent Age at
24 Hour protein/age presentation
SCr SAlb UA protein Cr ratio Kidney biopsy
Individual mg/dL g/dL (dipstick) g mg/mg (age at biopsy) Clinical courseyears
I:2 Deceased (Exact age of onset of symptoms and details of early presentation unknown) ESRD at age 50. Transplant at 51.
II:2 38 1.25 0.6 1.2 31 NA 2.2 FSGS (8 y) Steroid unresponsive. PE and DVT
Focal global sclerosis as adult.
(11 y)
II:4 37 4 0.5 1.4 41 1.4 3.2 Focal global sclerosis No steroid trial documented.
(9 y) Asymptomatic as an adult.
II:5 34 3.25 0.4 1.0 41 1.7 NA MCD (4 y) Steroid, mercaptopurine, and cyclo-
phosphamide unresponsive.
Intermittent edema.
III:2 12 1.83 0.1 0.4 41 2.0 NA MCD (6 1/2 y) Ongoing proteinuria. No steroid
trial recorded.
III:3 15 1.16 0.4 1.5 41 7.8 28.0 Mesangial Prolifera- Steroid, cyclosporine and chloram-
tive GN (19 mo) bucil unresponsive. ESRD at age
15. Hemodialysis dependent.
III:4 7 0.25 0.4 2.0 41 0.3 2.8 Focal global sclerosis Steroid unresponsive
(15 mo)
III:5 6 0.75 0.4 2.1 41 0.9 6.0 No steroid trial. Continued protein-
uria.
III:6 4 1 0.3 2.1 21 NA NA No steroid trial. Continued protein-
uria.
III:7 1 0.25 0.4 2.1 NA NA 5.2 No steroid trial.
Abbreviations are: SCr, serum creatinine; SAlb, serum albumin; UA, urine analysis; FSGS, focal segmental glomerular sclerosis; MCD, minimal
change disease; DVT, deep venous thrombosis; PE, pulmonary embolism; NA, not available.
cells using the Qiagen kit (Qiagen, Inc., Valencia, CA, generation denied renal disease in prior generations.
Segregation of the disease in CHP family 101 followedUSA). Fluorescently labeled primers for chromosome
19 markers D19S425, D19S208, D19S191, D19S224, and an autosomal dominant pattern. The family pedigree is
shown in Figure 1. Not all family members from genera-D19S220 were purchased from Research Genetics (Hunts-
ville, AL, USA). Markers were amplified using standard tion one are shown. The selected clinical features of
affected family members are described in Table 1. Ofprotocols and the products resolved on an ABI 377 auto-
matic sequencer (Applied Biosystems, Foster City, CA, the 10 affected members, the age of presentation ranged
from three months to four years, with a mean age ofUSA) and were analyzed using the GENOTYPER pro-
gram package [15]. onset of 18.4 months. Eight of 10 affected patients pre-
sented with periorbital and extremity edema. The re-
Linkage analysis maining two patients (III:6, III:7) were evaluated for
proteinuria prior to onset of symptoms. Twenty-four–Prior to recruitment of the family, a simulation analysis
using the computer program SLINK (abstract; Weeks et hour protein excretion ranged from 0.87 to 7.76 g, with
a mean of 2.32 g. Serum creatinine was in the normalal, Am J Human Genet 47:A204, 1990), gave an estimated
probability of observing a logarithm of odds (LOD) score range for age and weight of the patient at the time of
diagnosis (Table 1). Microscopic hematuria was notedof .2.0 of 93%, assuming a fully penetrant autosomal
dominant disease model and a disease allele frequency of in one member at presentation (III:2) and in two other
family members (II:2, III:3) during their clinical course.0.0001. Two-point linkage analysis was performed using
VITESSE with the same parameters as the simulation Hematuria was noted in family member II:5 after the
administration of cytotoxic agents and was diagnosed as[16]. A locus order cen-S425-S208-S191-S224-S220-tel
was taken from Mathis et al [9]. hemorrhagic cystitis. One of the affected family members
(III:6) was born with congenital corneal opacity (Peters
anomaly) and required corneal transplantation. None of
RESULTS
these individuals displayed any evidence of other causes
Clinical evaluation and family data of renal dysfunction, such as diabetes or collagen vascu-
lar disease.Children’s Hospital of Pittsburgh family #101 is a 17-
member kindred of mixed African American and Cauca- Of the six renal biopsies, five were available for review.
On light microscopy, focal global sclerosis (Fig. 2a) wassian heritage spanning three generations. One member
(II:6) is of African origin. Family members in the first seen in two patients (II:4 and III:4). Classic lesions of
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Fig. 2. Spectrum of pathological lesions. (a) A globally sclerotic glo-
merulus in a biopsy from case II:4 (3700). (b) Focal segmental sclerosis
seen in a renal biopsy from patient II:2 (3700). (c) A glomerulus
from case III:3 showing focal mesangial proliferation (3350). (d) An
essentially normal glomerulus illustrating the histologic appearance
classified as minimal change disease (3350). (e) Electron micrograph
of III:4 showing extensive foot process fusion.
FSGS (Fig. 2b) were seen in one case (II:2). Focal mesan- onstrated a moderate amount (21) of mesangial deposits
of IgM, whereas electron microscopy documented mes-gial proliferation (Fig. 2c) was seen in three cases (II:4,
III:3, III:4), and one of these could be classified as mesan- angial and paramesangial electron-dense deposits. Ultra-
structural examination of the remaining cases revealedgial proliferative GN (IgM nephropathy variant; III:3).
Immunofluorescence examination in this latter case dem- subendothelial granular translucent material in the glo-
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merular capillary loops and variable fusion of the podo- families. The Mathis et al family was Caucasian and
much larger (100 vs. 17 in our family), yet had a smallercyte foot processes (Fig. 2e). One case (II:5) was consid-
ered to represent MCD because all of the 24 glomeruli proportion of affected individuals (29 affected vs. 10 in
ours), indicating variable expressivisity and penetrancein two biopsies appeared to be morphologically normal
(Fig. 2d). of the trait. Patients in the Mathis et al family usually
presented with NS in adulthood (mean age at the fifthTwo family members (I:2 and III:3) progressed to re-
nal failure. Family member I:2 progressed to renal failure decade) and progressed to ESRD in a mean of nine
years. In contrast, CHP family 101 demonstrated com-in the fifth decade, was transplanted at age 51, and died
at age 57 of myocardial infarction and respiratory com- plete penetrance. Furthermore, the affected members
presented early in life (mean age 18.4 months, range 3plications. Family member III:3 abruptly progressed to
renal failure recently at age 15 after maintaining stable months to 4 years) and maintained normal or near nor-
mal renal function for several decades. Two family mem-renal function for the first 14 years of life. His serum
creatinine at 12 years of age was 0.5 mg/dL and was 0.9 bers in CHP family 101 developed ESRD, one in the
fifth decade of life and the other abruptly at age 15. Theto 1.0 mg/dL in the 14th year of life. He is currently
hemodialysis dependent. This individual had numerous clinical course of the affected individuals in CHP family
101 is somewhat unusual in that they had severe steroidinfectious episodes as an infant, including two episodes
of Hemophilus influenzae meningitis, leading to deaf- unresponsive NS with an onset at a young age, and,
except for the two individuals mentioned, did not prog-ness. He required repeated infusions of intravenous im-
munoglobulin for hypogammaglobulinemia. He also has ress to ESRD up to 30 years later. We speculate that
iatrogenic factors, including intravenous immunoglobu-severe pulmonary dysfunction secondary to presumed
undiagnosed episodes of pneumonia during his infancy lin, may have contributed to the rapid decline in renal
function in the 15-year-old member [17, 18].and childhood, leading to bilateral bronchiectasis. Most
Interestingly, the pathological abnormality seen in ourof the other individuals had mild clinical disease with
family varied from minimal change and mesangial prolif-intermittent edema, which appeared to be very slowly
erative GN to FSGS at the time of initial presentationprogressive. All of the affected children in the third gen-
(Fig. 2), in contrast to mostly FSGS seen in the familyeration have also been diagnosed with severe reactive
reported by Mathis et al [8, 9]. A biopsy of one of theairway disease. One individual (II:4) had remission of
affected members in our family (II:2) demonstrated clas-clinical symptoms at age 17 but continues to have pro-
sic focal segmental sclerosis (Fig. 2b), whereas two othersteinuria. All patients were nonresponsive to steroids and
(II:4, III:4) were noted to have focal global glomerulo-cytotoxic agents. DNA samples were collected from a
sclerosis with no segmental involvement (Fig. 2a). It istotal of 16 individuals, including 9 affected and 7 unaf-
possible that the biopsies of these two family membersfected, which included spouses.
and the member diagnosed with MCD (II:5) may have
Linkage analysis demonstrated FSGS lesions if serial sections of the
biopsy tissue were examined [19]. It has been postulatedThe family pedigree with five locus haplotypes of each
that MCD and FSGS could be variants of the same dis-available family member is shown in Figure 1. All af-
ease [1, 2]. As all three different histologic lesions werefected family members inherited the identical five locus
linked to the same localized chromosomal region in ourhaplotype and two point linkage analysis using this hap-
family, it is possible that the same locus or allele is re-lotype gave a maximum LOD score of 2.25 at u 5 0. Six
sponsible for the differing histopathologic manifesta-point linkage analysis using five locus genotypes gave a
tions. This supports the notion that in a subset of patientsmaximum LOD score of 2.41 at u 5 0. These results
with NS, MCD and FSGS may represent two ends ofconfirm the estimated maximum LOD score obtained in
the histologic spectrum of the same disease. However,the SLINK simulation analysis and provide evidence for
it is possible that modifying genes not yet identified coulda gene-causing autosomal dominant NS within the 7 cM
account for the differing histopathologic findings amongregion defined by markers D19S425 and D19S220.
family members. The different rates of progression and
outcome variability in the CHP 101 family and that of
DISCUSSION Mathis et al may be partly due to the different histologic
We have reported a kindred with familial NS, which manifestations at presentation in the two families, as
shows linkage to a region on chromosome 19q13, con- FSGS is typically associated with a faster rate of progres-
firming the findings of Mathis et al [9]. Phenotypic simi- sion to ESRD in comparison to MCD [1]. It is likely
larities between CHP family 101 and the family of Mathis that significant differences in the expression, penetrance,
et al include an autosomal dominant inheritance pattern, and progression of the disease in the Mathis et al and
as well as the presence of significant proteinuria. How- CHP families may be due to allele or locus heterogeneity
or epistatic and/or environmental factors.ever, there were significant differences between the two
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The region 19q13 defined by the markers used in this 003 nephrnav.htm) has been developed to provide more
information about this study.study spans a genetic distance of 7 cM. A mutation in
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